fosamprenavir/ritonavir
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), ViiV Healthcare, University of California, San Francisco, Radboud University Medical Center, Felizarta, Franco, M.D.
Conditions
HIV InfectionHIV InfectionsHIV-1 InfectionHealthyHypertriglyceridemiaInfection, Human Immunodeficiency Virus IOpioid Dependency
Phase 1
Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
CompletedNCT00877591
Start: 2008-04-30End: 2013-04-30Updated: 2014-05-06
Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
CompletedNCT00977301
Start: 2009-11-30End: 2010-08-31Target: 24Updated: 2020-11-30
Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects
TerminatedNCT01140412
Start: 2010-07-31End: 2010-10-31Updated: 2011-02-04
Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects
CompletedNCT01290211
Start: 2011-04-30End: 2011-06-30Updated: 2011-06-29